- Joined
- Jun 4, 2006
- Messages
- 102
- Reaction score
- 0
Mick Bhatia, lead researcher of the study and scientific director of McMaster's Stem Cell and Cancer Research Institute in the Michael G. DeGroote School of Medicine, said: "The unusual aspect of our finding is the way this human-ready drug actually kills cancer stem cells; by changing them into cells that are non-cancerous."
They talked about using an automated robotic system to identify usable compounds, but still I wonder if World Community Grid and other distributed computing projects played or will play a role:
The team also plan to analyze thousands of other compounds with their screening system in partnership with collaborations that include academic groups and industry.
From Medical News Today.